In the Wiemer Group, we explore how the human immune system can be harnessed for cancer therapy, with a growing emphasis on data-driven conceptual approaches to understanding immune regulation and therapeutic mechanisms. Our work integrates insights from immunology, molecular biology, and medicinal chemistry to identify promising directions for next-generation cancer treatments. As an academic research group, our goals are two-fold: (1) to develop new ideas, models, and frameworks that guide the discovery of future immunotherapies, and (2) to provide an outstanding training environment for students who will lead the next breakthroughs in cancer therapy.